Literature DB >> 32880613

COVID-19 and mRNA Vaccines-First Large Test for a New Approach.

Jennifer Abbasi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32880613     DOI: 10.1001/jama.2020.16866

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  33 in total

1.  Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness.

Authors:  Ousseny Zerbo; Bruce Fireman; Nicola P Klein
Journal:  Expert Rev Vaccines       Date:  2021-10-08       Impact factor: 5.683

2.  The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2.

Authors:  Hai Huang; Caili Zhang; Shuping Yang; Wen Xiao; Qian Zheng; Xiangrong Song
Journal:  J Control Release       Date:  2021-05-21       Impact factor: 9.776

Review 3.  Advances of nanomaterials-based strategies for fighting against COVID-19.

Authors:  Chunxi Zeng; Xucheng Hou; Margaret Bohmer; Yizhou Dong
Journal:  View (Beijing)       Date:  2021-05-05

Review 4.  Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination.

Authors:  Danilo Toni; Alexander E Merkler; Manuela De Michele; Joshua Kahan; Irene Berto; Oscar G Schiavo; Marta Iacobucci
Journal:  Circ Res       Date:  2022-04-14       Impact factor: 23.213

Review 5.  An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology.

Authors:  Louise M Gresham; Barbara Marzario; Jan Dutz; Mark G Kirchhof
Journal:  J Am Acad Dermatol       Date:  2021-01-19       Impact factor: 11.527

Review 6.  "COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment".

Authors:  Girish Gilly Munavalli; Rachel Guthridge; Siri Knutsen-Larson; Amy Brodsky; Ethan Matthew; Marina Landau
Journal:  Arch Dermatol Res       Date:  2021-02-09       Impact factor: 3.017

Review 7.  mRNA vaccine: a potential therapeutic strategy.

Authors:  Yang Wang; Ziqi Zhang; Jingwen Luo; Xuejiao Han; Yuquan Wei; Xiawei Wei
Journal:  Mol Cancer       Date:  2021-02-16       Impact factor: 27.401

Review 8.  SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?

Authors:  Saborni Chakraborty; Vamsee Mallajosyula; Cristina M Tato; Gene S Tan; Taia T Wang
Journal:  Adv Drug Deliv Rev       Date:  2021-01-20       Impact factor: 17.873

Review 9.  Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2.

Authors:  Javier T Granados-Riveron; Guillermo Aquino-Jarquin
Journal:  Biomed Pharmacother       Date:  2021-07-23       Impact factor: 6.529

Review 10.  BNT162b2 mRNA COVID-19 Vaccine: First Approval.

Authors:  Yvette N Lamb
Journal:  Drugs       Date:  2021-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.